Is Fondaparinux still in shortage in 2026? Get the latest update on availability, pricing, alternatives, and how to find it in stock near you.
If you rely on Fondaparinux (Arixtra) to prevent or treat blood clots, you may have noticed it's been harder to find at pharmacies over the past year. You're not imagining it. Fondaparinux has experienced intermittent supply disruptions that have left many patients scrambling to fill their prescriptions.
In this update, we'll cover the current shortage status, explain why it's happening, break down costs in 2026, and share practical steps you can take to get your medication.
As of early 2026, Fondaparinux continues to face intermittent supply challenges. Certain strengths — particularly the 2.5 mg and 7.5 mg prefilled syringes — have been harder to find at retail pharmacies. The situation varies by region and pharmacy, meaning some patients can find it easily while others face weeks-long waits.
The FDA and ASHP (American Society of Health-System Pharmacists) maintain drug shortage databases that track current supply issues. While Fondaparinux is not always listed as officially "in shortage," the practical reality for patients is that availability has been inconsistent.
The brand-name version, Arixtra, has been largely scaled back in the U.S. market by Viatris, meaning patients now depend almost entirely on generic Fondaparinux from manufacturers like Dr. Reddy's Laboratories.
Several factors are driving the supply challenges:
Fondaparinux is a synthetic pentasaccharide — a molecule made up of five linked sugars. Manufacturing this compound requires specialized facilities and processes that very few pharmaceutical companies have. This limits the number of producers who can make the generic version.
Only a handful of companies produce generic Fondaparinux for the U.S. market. When even one manufacturer experiences a production delay, recall, or raw material shortage, the impact on overall supply is significant.
Hospitals are major consumers of Fondaparinux for post-surgical blood clot prevention. Hospital purchasing contracts often take priority over retail pharmacy orders, leaving less supply available for outpatient pharmacies.
Global pharmaceutical supply chains remain under stress. From raw material sourcing to international shipping and domestic distribution, multiple points of failure can delay or reduce Fondaparinux availability.
For a deeper dive into these factors, read: Why Is Fondaparinux So Hard to Find?
Cost is a major concern for patients, especially during a shortage when options may be limited. Here's what you can expect to pay:
For a full breakdown of savings strategies, see: How to Save Money on Fondaparinux in 2026.
While no new formulations of Fondaparinux have launched recently, the anticoagulant market continues to evolve:
For a full comparison of alternative medications, see: Alternatives to Fondaparinux If You Can't Fill Your Prescription.
Even during supply disruptions, Fondaparinux is available at many pharmacies. Here's how to find it:
Medfinder lets you search for pharmacies near you that currently have Fondaparinux in stock. This is the fastest way to locate your medication without making dozens of phone calls.
Independent pharmacies and specialty pharmacies that handle injectable medications may have supply from distributors that chain pharmacies don't use. Hospital outpatient pharmacies are also worth checking.
Even if your pharmacy doesn't have Fondaparinux on the shelf today, they may be able to order it from their distributor. Ask about expected delivery times.
Your insurance plan's mail-order pharmacy may have access to different inventory. This can be especially convenient for ongoing prescriptions.
For more detailed tips, see: How to Find Fondaparinux in Stock Near You.
The Fondaparinux shortage in 2026 is a real challenge for patients who depend on this medication. While supply has been inconsistent, the drug is still being manufactured and is available at many pharmacies — it just takes more effort to find.
Here's what to remember:
Staying proactive about your prescription is the best way to ensure you don't miss a dose. Blood clots are serious — and having the right medication matters.
Healthcare providers: For tools and resources to help your patients find Fondaparinux, visit Medfinder for Providers. See also: Fondaparinux Shortage: What Providers Need to Know in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
